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Over 50% of people diagnosed with a severe mental illness, such as schizophrenia or 
bipolar disorder, will meet criteria for a substance use disorder in their lifetime. This dual 
disorder often starts during youth and leads to significant societal costs, including lower 
employability rates, more hospitalizations, and higher risk of homelessness and of suicide 
attempts when compared to those with a serious mental illness without substance misuse. 
Moreover, many individuals presenting with comorbid disorders also present with other 
psychological difficulties as well, such as personality disorders or anxiety and depression, 
also known as complex comorbid disorders. Transdiagnostic treatments that focus on 
core difficulties found in people with complex dual disorders, such as emotional regulation, 
are direly needed. Emotional regulation skills can help reduce distress related to psychotic 
symptoms and maintain abstinence in substance use disorders. New technologies in the 
field of communications have developed considerably over the past decade and have 
the potential to improve access to such treatments, a major problem in many health 
care settings. As such, this paper aims at: presenting core difficulties present in many 
individuals with dual disorders, reviewing the scientific literature pertaining to the use of 
mobile applications in mental health and addictions, and presenting the development and 
potential of a new application for emotional regulation for people with dual disorders.
Keywords: severe mental illness, dual disorders, schizophrenia, psychosis, substance use disorder, mental health 
apps, emotion regulation
INTRODUCTION
Severe mental illness (SMI) typically includes psychotic episodes and can be characterized by the 
presence of positive (e.g., delusions, hallucinations) symptoms, but also negative or depressive 
symptoms (e.g., flat affects, avolition) or symptoms of disorganized thought and behavior (1). It 
is also in this category that bipolar disorders are grouped, which are characterized inter alia by the 
alternation between depressive and manic or hypomanic episodes (i.e., irritable or abnormally high 
mood). It is estimated that about 3.5% of the population will be diagnosed with an SMI at some point 
in their lives—the highest incidence reported or recorded being between 15 and 30 years (2). SMI 
is also characterized by mild to moderate cognitive deficits in the majority of individuals (25% of 
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them will maintain a cognitive functioning within the norm) (2). 
Although they have traditionally received less attention than the 
symptoms associated with psychosis (e.g., positive symptoms), 
these features are among the most important determinants 
when it comes to estimating the patient’s capacity to function 
autonomously in his/her environment (2, 3).
SMIs are marked by social functioning difficulties (more 
specifically difficulties starting or maintaining a conversation, 
attaining a goal, or meeting basic needs requiring a simple 
conversation/interaction with others). Furthermore, these 
difficulties will lead to social integration problems that can 
occur throughout different stages of the disorder (2). Studies 
report that the fear of being stigmatized and the fear of being 
judged (the latter often linked to social phobia) are two of the 
most frequently reported obstacles to integration by participants 
(4). Because of its significant influence on an individual’s social 
integration capacity, an increasing number of interventions focus 
first and foremost on the individual’s functional capacities rather 
than solely on the reduction of symptoms (5).
In terms of clinical presentation and important difficulties 
people with SMI face, substance misuse needs to be addressed. 
Indeed, over half of people with an SMI will also have a lifetime 
substance use disorder (2, 6–8). A hypothesis that might explain 
this phenomenon is that individuals with SMI have a deficit in 
the reward circuit (i.e., neural network involving the ventral 
tegmental area and the nucleus accumbens) (9). This would 
make individuals with SMI sensitive to the gratifying effects of 
drugs, and so, it would be more difficult for them to resist the 
urge to consume (10, 11). However, it has been documented 
that people with SMI will use substances for similar reasons as 
those of people without SMI use, such as to feel more socially 
comfortable, to relax, to fight boredom, to feel euphoric, etc. 
Among the consequences related to dual disorders (i.e., SMI + 
substance use disorder), we find a higher rate of violent crimes 
(12, 13), more hospitalization, poorer compliance to treatment 
(13, 14), more relapses (14), a higher rate of sexually transmitted 
and blood-borne infections (STBBIs, including HIV) (15), a 
higher rate of homelessness (16, 17), more psychiatric symptoms 
(14, 18), poorer treatment outcomes (19), and a greater suicide 
rate (20) than people with a noncomorbid SMI.
DUAL DISORDERS AND COMMON 
COMORBIDITIES
Concurrent disorders are often accompanied by other issues 
that complicate the clinical presentation. SMI is unfortunately 
recognized to be associated with a greater prevalence of 
traumatic experiences. One in three patients with SMI currently 
undergoing treatment has a post-traumatic stress disorder 
(PTSD) (2). In dual disorders, the rate of comorbid PTSD and 
traumatic experiences is 49% and 73%, respectively. Traumatic 
experiences in individuals with psychotic disorders are related 
to more pronounced symptoms, increased use of services, 
more substance use, increased incidence of physical illness, 
and increased high-risk behaviors (2). Group B personality 
disorders (i.e., histrionic, borderline, narcissistic, and antisocial) 
are known for emotional instability, the tendency to dramatize 
certain situations, and unpredictable behaviors (1). A significant 
portion of these individuals struggle with substance use issues. 
An epidemiological study reports that 78% of individuals with 
borderline personality disorder met the criteria for substance 
use disorder at least once in their lifetime (21). Individuals 
with group B personalities are known to show more impulsive 
behavior, greater mood swings, and more depressive symptoms 
(22). In a study on psychotic disorders, a significant proportion 
of patients (close to 30%) diagnosed with SMI displayed 
problematic personality traits associated with group B without 
necessarily being diagnosed with a personality disorder. Wickett 
et al. (23) reported the presence of these traits in 27 (59%) of 
the 46 individuals enrolled in their studies [the presence of traits 
associated in this study was determined by the MCMI-III score 
(i.e., score between 75 and 84)].
Fifty percent of people recently diagnosed with SMI report 
experiencing depressive symptoms (24). In dual disorders, a 
study of the different clinical correlates in SMI with data from the 
National Institute of Mental Health (NIMH) in the United States 
(n=1,460) mentioned that 32.2% of individuals with concurrent 
disorders reported having a major depressive episode in the 
5 years preceding the study (18). Substance use in concomitant 
disorders is associated with more severe symptomatology than 
noncomorbid SMI (25). There is a much higher rate of completed 
suicides in SMI compared to the general population (147 to 750 
deaths per 100,000 persons compared to 11 per 100,000 per 
year) (2).
EMOTION REGULATION AND PSYCHOSIS
The study of emotional regulation is mainly based on two 
predominant conceptual frameworks (26). The first, Gross’s 
(27, 28) model, defines emotion regulation as the use of 
different strategies to increase, decrease, or maintain an affective 
experience and its expression. This model is mainly used when 
trying to establish the usefulness and/or effectiveness of specific 
emotion regulation techniques in psychiatric symptoms (26). 
The second model, presented by Gratz and Roemer (29), is more 
integrative. It addresses emotion regulation in the context of 
the general affective functioning of the individual, subdivided 
into four dimensions: 1) the awareness, understanding, and 
acceptance of affective experience; 2) the ability to engage in 
a goal-oriented activity and restrain from acting impulsively 
when experiencing negative emotions; 3) the ability to use 
techniques that are appropriate to the context in which one 
finds himself/herself to modulate the emotional response; and 
4) the openness to feeling negative emotions when pursuing a 
meaningful activity. According to this model, an individual 
having difficulty regulating his/her emotions will thus present 
difficulties in one or more of these dimensions (26). Studies 
using this model report that difficulties in all four dimensions 
are frequently observed in depressive, anxiety, eating, substance 
use, and borderline personality disorders (26), some of which are 
frequently associated with SMI (see the section Dual Disorders 
and Common Comorbidities).
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Emotion regulation difficulties have also been identified as 
one of the explanatory factors for substance use in schizophrenia. 
In their model, Blanchard et al. (30) suggest that individuals with 
certain personality traits (i.e., negative affectivity/neuroticism 
and disinhibition/impulsivity) who also show difficulties in 
applying effective coping methods (e.g., interpersonal problem-
solving) are more at risk of using substances to cope with negative 
emotion when encountering important stresses. This model has 
been partly supported by the literature (31).
Studies have shown that the use of good emotion regulation 
strategies leads to a reduction in the intensity and distress 
associated with auditory hallucinations (32, 33). It would also 
lead to a decrease in the likelihood of developing psychotic 
symptoms and prescribing medication in “high-risk” individuals 
(34) and a reduction in the relapse rate (35). Emotion regulation 
difficulties are central in comorbidities associated with SMI. 
Emotional regulation difficulties in individuals diagnosed with 
PTSD would be associated with, among other things, difficulties 
in functioning and more pronounced symptomatology (36). 
A study conducted by Ehring and Quack (37) on individuals 
with PTSD (n = 616) demonstrated that the severity of trauma-
related symptoms is negatively associated with participants’ 
emotional regulation abilities (i.e., greater difficulties = more 
severe symptomatology). The authors of the study also point out 
that there are no differences between individuals with complex 
PTSD (i.e., repeated abuse, often starting in childhood) and 
those experiencing “one” trauma, with regard to their abilities to 
regulate their emotions. These difficulties are also a central issue 
in group B personality disorders (38) and substance use disorders 
(39). Indeed, many individuals will use substances in an attempt 
to cope with difficult emotions, as an avoidance strategy.
Today, more and more authors place a strong emphasis 
on emotional processes in the treatment of SMIs such as 
schizophrenia (40). This phenomenon may be explained in part 
by the fact that the level of distress experienced is proportional 
to the intensity of psychotic symptoms reported (41). Studies on 
emotion regulation within SMI have focused primarily on the 
use of two cognitive strategies—suppression and re-evaluation. 
Suppression is a strategy where the individual tries to voluntarily 
limit the expression of an emotion when it occurs; it is 
categorized as a regulation technique centered on the emotional 
response. Re-evaluation is a technique in which the individual 
tries to modify the meaning of an event in order to change the 
emotional response; it is a strategy centered on the antecedents 
of the emotional response (i.e., before feeling the emotion) (42). 
As for the suppression strategy, two diverging trends seem to 
emerge from the studies. The explanatory model of blunted 
affects by Kring and Werner (43) presents this manifestation as 
resulting from difficulties in increasing the affective experience 
and a less adapted use of regulation strategies. Following 
this idea, researchers have identified the use of suppression 
strategies as one of the potential explanations of blunted affect 
(42, 44, 45). Other studies report that participants with SMI use 
suppression as much as control participants (42, 46). Studies 
seem more consistent with the fact that people with SMI use 
fewer reassessment strategies than the average person (45, 
46). This strategy is known to be associated with a reduction 
in depressed mood and better social functioning (42). The 
emotional processes observed in substance use disorders suggest 
that the search for stimulation through the consumption of 
substances would aim to lessen the experience of anhedonia, an 
often-reported state in this population (47, 48). We can also find 
more recent results going in the same direction where a study 
reported positive correlations between novelty research, craving, 
and anhedonia in patients previously dependent on opioids or 
alcohol (49). Those correlations have been reproduced through 
several studies; research on the subject identifies, in a somewhat 
paradoxical way, that the experience of anhedonia may be a 
consequence of substance use (48).
Emotion regulation is central to third-wave cognitive behavioral 
therapy approaches (50). These therapies often encourage the use 
of mindfulness and appear to have encouraging results in terms of 
improving emotion regulation when employed with individuals 
with psychotic disorders (51) as well as those with substance 
use disorders (52). Among these approaches, some of the better 
known are dialectical behavior therapy, mindfulness therapy, 
and acceptance and commitment therapy (ACT). Dialectical 
behavioral therapy is an intervention initially intended for 
individuals with borderline personality disorder with a suicidal 
tendency; it was subsequently adapted to all issues involving 
emotional regulation difficulties (28). This therapy proposes 
strategies for emotion regulation according to six dimensions: 
1) emotional vulnerability factors; 2) events (internal/external) 
leading to an emotional response; 3) interpretation of events; 
4) the emotional response (physiological, cognitive, experiential 
aspects)…; 5) the verbal/nonverbal response and the actions 
taken; and 6) the impacts of the emotion felt (e.g., secondary 
emotion) (53). Mindfulness-based therapy is an intervention 
aimed at developing awareness of the present moment by taking 
an attitude of nonjudgment (28). Finally, ACT promotes the 
acceptance emotional states in order to help individuals commit 
to goals in accordance with their values (54). Studies support 
that this intervention is associated with an improvement in 
emotion regulation and a decrease in anxiety and depression 
symptoms for those with early psychosis (51) as well as those 
with SMI with comorbid traumatic childhood experiences 
(55). Third-wave treatment among users of different substance 
categories also produced encouraging results in which there was 
a significant reduction in drug use but also a better retention 
than in treatment as usual (56). Interventions, such as third-
wave treatments, that offer better emotion regulation strategies 
to people with comorbid disorders, namely SMI with substance 
misuse, are needed and could likely improve the individuals’ 
lives not only by diminishing the need to use drugs to cope 
but  also by helping decrease distress, associated with various 
clinical presentations.
ACCESS TO TREATMENT
Difficulties in accessing mental health services are a major global 
concern, particularly in relation to drug and alcohol addiction 
issues (57, 58). This situation is even more concerning given 
the link between difficulties in receiving services and the onset 
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use of injectable drugs among individuals already experiencing 
substance use disorders (59). In order to better target accessibility 
needs, Lesvesque and colleagues (60) suggest conceptualizing 
access to services in five dimensions, derived from a synthesis 
of the literature on the subject: accessibility, acceptability, 
availability, costs, and relevance of services. Accessibility refers 
to the importance of services being known to the population. 
This is particularly important considering findings that suggest 
that individuals with substance abuse disorders are more likely 
to favor familiar treatments (61). Acceptability refers to the 
cultural and social dimensions that must be compatible with the 
type of service offered (e.g., belief in the cause and treatment of 
diseases). Availability refers to the resources required for a facility 
to provide services to the entire population and to be “physically” 
accessible (e.g., within-territory distribution based on the density 
of population, flexibility of work schedules, and adaptation of the 
environment for people with reduced mobility). Service costs 
refer to the capacity of individuals to spend money in order to 
receive a service. Finally, the dimension of relevance of services 
highlights the importance of matching services to the needs 
of clients.
Issues regarding the availability of services seem to be one of 
the main barriers to access in addiction issues, particularly in 
relation to the problem of waiting time (59, 61–65). Studies on 
this matter conducted among individuals with dual disorders 
also report difficulties in the relevance of care provided in 
this population, who, when compared to individuals with a 
unique diagnosis of substance use disorder, appear as those 
being the least satisfied with services rendered due to a lack 
of compatibility with their needs (e.g., treatment setting for 
a specific disorder that doesn’t accept people with substance 
use disorder) (66). Acceptability of care has also emerged 
as an important issue in this population—with the majority 
of individuals indicating that they prefer to manage their 
symptoms independently (66). In addition, individuals with 
dual disorders often report feeling excluded from health care 
services because of the dual diagnosis (mental health services 
do not accept them because of substance use disorder and 
vice versa). A preference for more personalized services, such 
as integrated treatments, was mentioned along with detailed 
reports regarding the lack of perceived usefulness of a parallel 
treatment focusing on a single diagnosis at a time (67).
Canadian studies on access to services seem to raise the same 
concerns as elsewhere in the world with a few exceptions. As the 
public health system bears the costs of certain interventions such as 
the use of opioid antagonists, it is possible that issues related to the 
cost of certain services may be less significant than in other countries 
lacking a similar structure (64). In Ontario, a report on the quality 
of mental health and addiction services states that individuals 
unable to access services reported problems of availability (i.e., 
difficulties with language, service hours in conflict with working 
hours), accessibility (i.e., not knowing where/how to get help), costs 
related to services (e.g., insurance does not cover certain services), 
and acceptability (e.g., fear of stigma related to the request for help) 
(62). In Quebec, a study by Champagne and Contandriopoulos 
(68) on the impact of the recent reorganization of health care 
services between 2015 and 2017 reveals a number of disturbing 
findings regarding the accessibility of care in mental health and 
addiction treatment (68). Based on the information collected in 
the integrated health and social service centers [Centres Intégrés 
de Santé et de Services Sociaux (CISS)], the organizations in charge 
of providing services in the region, researchers found that access 
to mental health services remains problematic and inadequate for 
the whole region (i.e., less privileged centers offer fewer services 
than more privileged centers). With regard to access to addiction 
services, researchers point out that although several centers have 
recently integrated detection and early intervention services, only 
one CISSS (center) had a satisfactory accessibility score (i.e., 79% of 
patients had been consulted within 15 days).
THE SMARTPHONE, AN INCREASINGLY 
POPULAR TOOL
Assessment
We have witnessed a significant increase of people with cell 
phones from 2010 to 2015 (69). This phenomenon is observed 
in several age groups, different socioeconomic levels, and several 
different cultures from around the world (70). A study of patients 
attending hospital emergency departments reported that 70% 
(176/249) of individuals struggling with homelessness in the 
past year had a cell phone (or a smartphone—76/176, 43.2%) 
in their possession (71). In its annual report on the issue, the 
United Nations–sponsored international telecommunications 
union estimates that 90.3% of people in developed countries 
have a subscription to a mobile phone service (72). With 
regard to people suffering from a psychotic disorder, a survey 
assessing 1,592 individuals with a serious mental illness (i.e., 
schizophrenia, schizoaffective disorder, and bipolar disorder) 
reported that 72% of participants had a smartphone (73). The 
smartphone adaptation of mental health interventions offers 
several advantages that can potentially mitigate certain problems 
encountered by the community. It could allow the assessment 
of individuals in their natural environment, where some mental 
health issue originally emerged, instead of studying them in more 
artificial contexts such as a clinic or a hospital (5). Furthermore, 
by allowing someone to assess his/her current state (see section 
below) and to access support at any time (and any place) needed, 
this new medium could be part of the answer to treatment 
accessibility issues (74).
Data collection using applications can be organized in different 
ways. Among these approaches, the ecological momentary 
assessment (EMA), defined as “methods using repeated 
collection of real-time data on subjects’ behavior and experience 
in their natural environments” (75, p. 3), appears as a promising 
method in the use of new technologies in mental health and 
addiction (70). Shiffman et al. have published a comprehensive 
record on the issue in the 2008 Annual Review of Clinical 
Psychology (75). The authors report that this method makes 
it possible to overcome the important stakes of memory bias 
(e.g., memory salience depending on emotional valence), which 
researchers are necessarily confronted with when relying on 
retrospective evaluation of a phenomenon occurring in the 
natural environment of the subject. They also mention that this 
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method makes it possible to capture more precisely the variations 
of a phenomenon over time (for example, mood levels during 
the week evaluated twice a day) because it makes repeated 
measurements of the phenomenon in a relatively small time gap. 
These two factors contribute to increasing the ecological validity 
of the EMA (70, 76, 77). This greater validity could potentially 
help better understand the “risk situation–feelings of craving–
consumption of substances” sequence in substance use disorders 
(78). Shiffman et al. (75) proposed four potential uses of EMA 
in research: identifying individual differences by comparing 
multiple groups, tracking the “natural history” of one or more 
topics to capture variations in phenomena across time, studying 
the interaction of two or more phenomena in an individual’s 
environment (e.g., mood levels following a stressful event), 
and studying the temporal sequence of certain phenomena 
(e.g., contextual or internal factors leading to substance use). 
By offering the possibility to perform assessments on a regular 
basis or according to the events under study, the EMA is flexible 
enough to adapt to the study of several psychological phenomena 
such as episodes of craving in substance use—an event occurring 
in a small time frame—or general mood that often requires 
multiple assessments (75). Much research in the field of mental 
health applications has incorporated this approach. Researchers 
working among adolescents have reported that using this method 
would produce valid results in the assessment of symptoms, 
environmental contexts, and coping strategies used in real 
time by users (79). A study by Comulada et al. (80) including 
adolescents with substance use disorders (13 to 18 years old) 
was able to clarify the external and internal cues related to drugs 
and alcohol consumption. With the help of an application-based 
EMA, these researchers were able to establish that, compared to 
other drugs, alcohol consumption occurs mainly on evenings 
and weekends. In the field of SMI, research using this method 
has suggested a link between the environmental context and the 
intensity of hallucinations (81) and a greater reactivity to daily 
stresses between individuals at risk of developing psychosis (82).
Intervention
Following the same principles as EMA, interventions using 
smartphone applications or ecological momentary intervention 
(EMI) are considered interventions in the individual’s everyday 
environment (83). Although the study of these interventions is 
still in its infancy, researchers have reported encouraging results 
for the use of EMI for several health issues, such as weight loss 
(84), reduction of anxiety levels (85), reduction in the number 
of cigarettes smoked (86), and increase in physical activity (87).
The National Institute of Mental Health (NIMH) in the United 
States identifies six categories of mental health apps (74):
a) Applications designed to promote autonomous disease 
management that provide feedback to the user based 
on information previously entered.
b) Applications to correct thinking biases (i.e., cognitive 
restructuring), mainly for people with psychotic 
disorders.
c) Applications for skills training (e.g., stress management).
d) Applications to get in touch with a mental health 
professional.
e) Applications that automatically record indirect 
indicators believed to be related to a disease (e.g., 
number of text messages sent for a socialization index, 
duration of calls,…).
f) Applications that collect multiple categories of data 
automatically.
Growing evidence tends to support these different applications 
as effective methods of prevention and intervention (70). Among 
other things, these apps have already been associated with a 
reduction in depressive symptomatology and anxiety and an 
improvement in substance use problems in several studies (88). 
However, it is important to note that this field of research is 
still young; the majority of research published in this field are 
pilot studies with no comparison group or randomized studies 
[Randomized controled trials (RCTs)] that have not yet been 
replicated (89). Recent research has also reported that this 
intervention format is well received by adolescents dealing with 
mental health issues (90, 91) or physical health issues (92).
In the field of SMI, a literature review by Firth and Torous (93) 
identified five applications, evaluated in seven separate articles—
those apps were primarily designed to promote self-management 
of the disease. The authors report that the majority of applications 
were very well received by participants, with an estimated average 
use of 85% of the days in which the studies were conducted, 3.95 
times per day. It also states that people at risk for a psychotic 
episode and those who just experienced their first psychotic 
episode were most likely to use the app. Another study involving 
33 individuals with SMI or schizoaffective disorder assessed the 
feasibility and acceptability of the FOCUS app, an application 
offering the possibility of obtaining clinician assistance, and 
reported positive results going in the same direction (use: 86.5% 
of days, 5.2 times per day) (94). An original aspect of this study 
was that the design of the application took into consideration the 
cognitive impairments of the targeted population (95). A recent 
study by Schlosser et al. (96) has also reported encouraging 
results on the use of the PRIME application (i.e., personalized 
real-time intervention for motivational enhancement) among 
individuals who have recently experienced a first psychotic 
episode. Aimed at fostering goals for better health, quality of 
life, interpersonal relationships, and greater productivity, PRIME 
invited participants to select one of 36 life goals (e.g., improve 
my relationship with my family) that they wish to pursue. Short-
term goals derived from life goals (e.g., doing a fun activity with 
a family member) were then suggested to the participant. The 
application also allowed users to send messages to experienced 
clinicians and other users of the application on an online 
platform for advice or support to achieve their goals. Researchers 
report that individuals who used the app over a 12-week period 
significantly improved their sense of self-efficacy and motivation 
and had a significant reduction in the severity of their depressive 
symptoms and defeatist thoughts (96).
Encouraging results have also been seen for applications 
targeting disorders that are often comorbid in SMI. In September 
2018, the Food and Drug Administration (FDA) authorized 
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the marketing of the first application designed to assist in the 
treatment of substance use disorders, the application reSET. It 
is the first application of its kind available only under medical 
prescription (97). The application consists of a contingency 
management module of 62 exercises aiming at enhancing 
personal well-being without resorting to substance use (i.e., how 
to improve communication, mood management, prevention of 
transmission of sexually transmitted infections, …). In order to 
facilitate monitoring, the user’s activity on the application is listed 
on a web page accessible to the physician (97, 98). The validation 
study of the application, performed with 507 people, demonstrated 
that the use of the application was associated with more days of 
abstinence and a lower rate of attrition than in the treatment-as-
usual condition (98). It is important to mention that this study, 
which served as justification for the approval of the application 
by the FDA, was performed on a desktop-based intervention, 
which was subsequently adapted to the format of a mobile 
application (97, 98). In the adult cannabis-using population, a 
mobile app called Stop-cannabis was developed in Switzerland 
by one of the authors (YK) and colleagues and reported more 
than 73,000 users in 4 years (currently about 1,300 active users 
and 13,000 sessions per month). Based on the self-determination 
theory, this application aims to promote autonomy, competence, 
and relatedness as part of a process to reduce cannabis use. 
Following these principles, the various interventions offered by 
the application are based on brief intervention in substance use 
disorder, motivational interviewing, and the principles of relapse 
prevention for substance use disorder (99). More specifically, 
the application first gives access to a series of psychoeducation 
modules on the effects of cannabis withdrawal and suggests 
alternatives to consumption for a craving episode (e.g., call a 
loved one, entertain yourself on social networks). Following 
the principles of motivational interviewing, the application 
allows the user to identify the advantages and disadvantages of 
stopping cannabis use. The home page also displays several cues 
to facilitate cannabis cessation (i.e., the number of days without 
consumption, the amount of money saved due to the cessation 
of consumption, and the possibility of purchasing rewards after 
a certain number of days without taking cannabis). In 2016, an 
analysis of data related to 22,000 users showed that they compiled 
722,000 app sessions, with more than 30% of people having more 
than 6 sessions. Furthermore, a subgroup of 10% of users had 
performed 20 or more sessions. In terms of satisfaction, around 
70% of them reported daily use of the app, and 80% reported that 
the app helped them to stop or reduce cannabis consumption “a 
little” or “a lot” (99). The Stop-cannabis app is currently under 
validation, and preliminary results demonstrate its feasibility 
and potential for cannabis adult users wishing to stop using. This 
application combined with an EMA program is now under study 
with adolescents with dual disorders (100). Young cannabis users 
(mean age: 20 years) who followed two sessions of motivational 
enhancement therapy combined with a mobile intervention 
designed to prevent relapse have reported a reduction of the 
craving sensation and a decrease in the amount of cannabis 
consumed (101). Furthermore, several cannabis-related 
psychoeducation online platforms were launched recently, but 
the evidence on their effectiveness is limited, as they have rarely 
been properly evaluated with regard to the content quality (102). 
These results are particularly encouraging for some countries 
such as Canada (the first G-7 country to legalize cannabis), 
knowing that the profiles of cannabis users in this country are 
quite different from those of users of other substances, with 
most cannabis users being under the age of 20 and still in high 
school. This profile should influence the content of the treatment 
and the manner in which the treatment is offered (103). Many 
youths will wait years before deciding to seek professional help 
for their cannabis use. This is partly due to the stigma associated 
with seeking professional help, as well as the fact that it can 
take that long for youths to realize that their cannabis use might 
be a problem.
In alcohol-related problems, researchers using an application 
designed to provide support to people with alcoholism 
(Addiction—Comprehensive Health Enhancement Support 
System or A-CHESS) were able to partially predict the number of 
days of consumption based on the level of use of the application 
by the user (i.e., number of times spent on the application, 
number of pages viewed) (104). As in the case of the Stop-
cannabis application presented above, the design of the A-CHESS 
application was based on the model of the self-determination 
theory. In trauma-related conditions, Possemato et al. (105) 
evaluated the effectiveness of an application (PTSD Coach) in 
reducing the symptoms associated with trauma in groups of 
veterans diagnosed with PTSD separated into two conditions 
(application with or without clinician assistance). The application 
has been associated with a decrease in symptoms under both 
conditions, with a significant benefit for the clinician-assisted 
condition. Other studies also report positive outcomes with the 
use of mobile applications for the management of different mood 
disorders (106–108).
Some recent research in mental health apps has evaluated the 
effectiveness of interventions that promote emotion regulation. 
To date, two applications were developed for a population with 
borderline personality disorder. EMOTEO, an application 
developed by a research team at the University of Geneva, 
was developed with the aim of providing emotional support 
during crises occurring between consultation sessions with the 
health care team (109). It allows the user to use mindfulness or 
distraction exercises according to the level of distress that has 
been reported initially using a distress scale ranging from 0 to 
10 (i.e., mindfulness exercise when the tension is between 1 
and 6 and distraction exercises when it is between 7 and 10—
following the idea that users in intense emotional distress don’t 
have a lot of resources to focus on a more complex exercise). 
The user is invited to report his/her level of distress once again 
after completing the exercise. The levels of distress that have 
been reported over time are reported on a graphic accessible 
from the main menu. The application also allows a direct call 
to emergency services if the app user feels the need to make 
one (109). DBT Coach is an application designed to promote 
the implementation of new skills acquired in therapy in the 
natural environment of the individual. More specifically, it 
aims to help the user develop the competency of the opposite 
action, a technique taught in DBT that consists of acting in a 
way that neutralizes a negative overwhelming emotion (110). 
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In order to suggest an opposite action adequate for the state 
of the individual, the application first asks the user to evaluate 
the intensity (on a scale of 0 to 10) and the quality of the 
emotion felt. After this information is entered, the program 
asks the individual whether or not he/she is ready to change the 
emotion. In the case of a positive response, the application will 
ask the user to indicate a specific action urge that he/she feels in 
connection with the reported emotion and will then provide a 
list of opposing actions that can be performed in response to this 
emotion. A negative answer will show windows where the user 
can indicate the “pros” and the “cons” to changing an emotion. 
Both applications have shown promising results in reducing 
the distress associated with a dysphoric mood, in reducing the 
“urgency to consume” (“craving”), and in the improvement of 
the depressive state (109, 110).
Mobile apps are increasingly recognized as effective tools 
for facilitating behavioral change (111). Their practical format 
facilitates the implementation of new strategies directly in 
the environment where their difficulties have emerged (5). 
Emotion regulation applications help individuals manage 
the different features of an emotional reaction when they 
occur in their environment. Following this principle, several 
mood-enhancing applications have been shown to be 
effective in reducing anxiety levels (e.g., 88, 112, 113). and 
improving depressive symptoms (e.g., 107, 108, 112, 114), two 
emotions known to increase the risk of relapse in substance 
use (115, 116). Applications could then potentially reduce the 
risk of relapse by aiming to stabilize the emotions associated 
with it.
Challenges and Limitations
Issues of security and privacy of applications are a major barrier 
to the acceptability of mental health applications, particularly 
when it comes to the transmission of non-Internet information 
(117). Not only does the information collected have the potential 
to be detrimental to the individual; applications may record 
a substantial amount of data on the individual [e.g., visited 
environments that have been recorded through geo-location 
system (118)]. Studies report very few mental health applications 
with an adequate privacy policy or secure data transmission 
methods (119–121). Huckvale et al. (122) conducted a systematic 
assessment of the applications presented on the English National 
Health Service (NHS) website, a public health organization with 
a mandate to ensure compliance with data protection regulations 
in England (122). Applications were evaluated based on their 
compliance with data collection/transmission/storage guidelines, 
confidentiality, privacy policy content, and the adequacy of 
these policies for the application’s actual behavior. One of the 
main findings reported by the research team concerns the high 
variability of the security level of the applications. Only one-third 
of the apps available had a confidentiality policy, which, in most 
cases, was incomplete (e.g., no specification on the use of data 
by a third party or incomplete explanations of the process for 
requesting changes to registered data as allowed by law). The 
study also reports that a large number of applications stored and 
transmitted unencrypted personal information. In light of these 
findings, the researchers point out that enforcement accreditation 
by a government agency does not guarantee the security of the 
data that will be recorded and invite users to exercise caution. 
Some authors also link the lack of consistency in the security of 
applications to the fact that government regulations in this field 
are sometimes ambiguous—e.g., an application pretending to cure 
a condition will not be subject to the same level of evaluation as 
an application designed to “improve mood” (89). Unfortunately, 
policies protecting app users are not rigorously being applied 
today and are lacking information in some important areas such 
as the use of data by a third party (121). As a result, users are 
encouraged to exercise caution when choosing a mental health 
application (74).
The speed at which technology is evolving today makes it 
difficult to accommodate the empirical validation process, which 
always requires a certain amount of time (74). Moreover, several 
issues regarding the validation of EMA tools are still in need of 
attention. First, although the EMA is more suitable for capturing 
intra-individual differences over time, this is not always the 
case for recall-based questionnaires (75). One challenge in 
this situation would be to adapt and validate tools compatible 
with the characteristics of the EMA. Furthermore, very few 
studies have examined the psychometric properties of tools 
used to collect information on mobile phones. These properties 
could potentially differ from those used for more traditional 
questionnaires, because they are not always used in the same 
context—e.g., users could fill out the questionnaire on their 
phone while they perform other tasks at home (123). Finally, 
it is possible that the small number of items generally used in 
EMA tools may produce limited results where we only scratch 
the surface of a particular phenomenon.
It is important to mention that the use of mental health apps in 
a population presenting a substance use disorder carries a risk of 
cross-dependence (124). Several studies have found similarities 
between certain behaviors associated with the problematic use 
of the Internet (i.e., gambling, compulsive pornography viewing) 
and substance use problems, including 1) unsuccessful attempts 
to reduce or put an end to the problematic behavior, 2) concerns 
(feeling of craving) leading to problems of functioning, and 
3) continuation of behavior despite deleterious effects (124–126). 
There is also evidence of an association between behavioral 
addiction (i.e., pathological gambling, compulsive buying, 
Internet addiction, work addiction, and exercise addiction) and 
problematic use of mobile phones in youth (127).
CONCLUSION
The treatment of individuals with SMI is often long and complex, 
in part because of the important functioning impairments but 
also because of the clinical presentation. The clinical presentation 
is often complicated by the presence of many comorbidities, 
such as substance use disorders, which are more often the 
rule than the exception. As in other mental health conditions, 
individuals with SMI and comorbid substance misuse often face 
accessibility difficulties for treatments offered in mental health 
settings. The mobile phone could potentially be part of the 
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solution to this issue by providing immediate access to strategies, 
when needed. Studies on this new form of intervention method 
report encouraging results for several psychiatric conditions. 
However, more research with comparison groups is needed to 
determine their clinical efficacy with greater certainty. In terms 
of intervention techniques, treatments aimed at improving 
emotion regulation have been shown to be effective for people 
with different diagnoses, including SMI and substance misuse.
In this perspective, an intervention promoting the development 
of emotional regulation skills for a population with comorbid 
SMI and substance misuse could potentially facilitate access 
to care and promote better management for those individuals. 
Our research team is now working on the development and 
evaluation of such an application, focusing on emotional 
regulation, that takes into account the specific characteristics of 
this population by applying the rules for designing applications 
for persons with cognitive deficits (95). The application for dual 
disorders, called Chill Time, includes a module dedicated to 
assessing distress and a module offering different intervention 
strategies primarily based on cognitive behavioral and third-wave 
strategies for emotion regulation. The application consists of 20 
exercises divided into four categories: 1) cognitive, 2) emotional, 
3) behavioral, and 4) spiritual strategies. Each of the strategies 
employed by the user is evaluated on its perceived usefulness 
once the exercise is completed. The application is currently under 
final development and validation. Should the results be positive, 
such an application may increase access to services and help link 
actual in vivo strategies with therapeutic outcomes, as assessed 
by clinicians. The assessment module includes a notification 
system that is similar to what can be observed with other social 
network apps; two alerts per day in total will be sent to the user. 
Once the notification is opened, the user will be redirected to the 
application, where he/she will be asked to rate his/her distress 
on a scale of three anchor points (i.e., good, neutral, not good). 
Should the response be neutral or negative, the user is redirected 
to a list of two exercises he/she could perform to emotionally 
self-regulate (stemming from two different categories). The two 
suggested exercises are chosen on the basis of the user’s past 
evaluations of the strategies’ usefulness (the exercises offered 
are initially randomly offered until the application has collected 
enough information on the preferences of the users).
Mobile applications have the potential to assist people with 
dual disorders in using strategies between treatment sessions 
without having to rely on their memory. Future studies are needed 
in order to demonstrate their efficacy and to offer profiles of 
emotional strategies used and their impact on substance misuse. 
Although multiple applications are being developed, only those 
with strong empirical support should be recommended and used.
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